Context Therapeutics Inc. — Director's Dealing 2026

Feb 23, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2026-02-19

Reporting Person: Lehr Martin A. (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-19	Stock Option (right to buy)	$2.32	A	815000	Acquired	2036-02-18	Common Stock (815000)	Direct

Footnotes

F1: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.